Corrigendum to “Development and Evaluation of an Immuno-Capture Enzyme-Linked Immunosorbent Assay to Quantify the <i>Mycoplasma capricolum</i> subsp. Capripneumoniae (Mccp) Protein in Contagious Caprine Pleuropneumonia (CCPP) Vaccine”

Baziki, Jean de Dieu; Charles, Bodjo S.; Nwankpa, Nick; Maina, Naomi; Chitsungo, Ethel; Boukary, Cisse Rahamatou Moustapha; Tefera, Takele A.; Nwankpa, Rume Veronica; Mwangi, Nduta

doi:10.1155/2021/9813273

Cited by 4 publications

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This ELISA is 93% sensitive and 88% specific, and can help in detection of antibodies for the diagnosis CCPP and for sero-surveillance during vaccination campaigns (Baziki et al 2019). An immunocapture ELISA (ICE) has been developed by Baziki et al (2021) for specific detection and quantification of the Mccp antigen in the CCPP vaccine. In vitro ICE method has shown correlation with an in vivo sero-conversion in goats and a sensitivity of 30 ng/ml (Baziki et al 2021).…”

Section: Common Diagnostic Tests For Ccppmentioning

confidence: 99%

See 1 more Smart Citation

A mini-review on diagnosis of contagious caprine pleuropneumonia

Rather

Parray

Ain

et al. 2021

Indian J of Anim Sci

View full text Add to dashboard Cite

Diagnosis of contagious caprine pleuropneumonia is imperative for timely detection and devising interventions that prevent disease spread and loss to farmers. Diagnosis of contagious caprine pleuropneumonia involves clinical signs, gross morphological lesions on postmortem, histopathology, culture and isolation, hematological, biochemical, serological and molecular diagnostic tests. Culture and isolation confirms the disease however it has been costly, cumbersome and difficult owing to the requirements of specific media, slow and difficult growth of causative agent Mycoplasma capricolum subsp. capripneumoniae. With the recent developments, diagnosis has comparatively eased by novel readymade media, advanced serological latex agglutination test (LAT), competitive enzyme linked immunosorbent assay (cELISA) or gene-based amplification of DNA, viz. polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP), hybridization and sequencing than the cumbersome and lengthy conventional tests; however they have financial implications and require sophisticated laboratory infrastructure and technical manpower. The latex agglutination test (LAT) is rapid, simple, and better test for field and real-time diagnosis applicable to whole blood or serum and is more sensitive than the compliment fixation test (CFT) and easier than the cELISA. PCR and monoclonal antibody based ELISA being specific aid to confirmation of CCPP. Future thrust is on developing rapid, sensitive, and specific tests that are cheap and convenient for field application.

show abstract

Section: Common Diagnostic Tests For Ccppmentioning

confidence: 99%

“…An immunocapture ELISA (ICE) has been developed by Baziki et al (2021) for specific detection and quantification of the Mccp antigen in the CCPP vaccine. In vitro ICE method has shown correlation with an in vivo sero-conversion in goats and a sensitivity of 30 ng/ml (Baziki et al 2021).…”

Section: Common Diagnostic Tests For Ccppmentioning

confidence: 99%

A mini-review on diagnosis of contagious caprine pleuropneumonia

Rather

Parray

Ain

et al. 2021

Indian J of Anim Sci

View full text Add to dashboard Cite

show abstract

Adoption of veterinary vaccines, determining factors, and barriers in Southwest Ethiopia: Implications for livestock health and disease management strategies

Robi,

Bogale,

Temteme

et al. 2024

Preventive Veterinary Medicine

View full text Add to dashboard Cite

Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives

Dawood

Algharib

Zhao

et al. 2022

Front. Cell. Infect. Microbiol.

View full text Add to dashboard Cite

Mycoplasmas as economically important and pantropic pathogens can cause similar clinical diseases in different hosts by eluding host defense and establishing their niches despite their limited metabolic capacities. Besides, enormous undiscovered virulence has a fundamental role in the pathogenesis of pathogenic mycoplasmas. On the other hand, they are host-specific pathogens with some highly pathogenic members that can colonize a vast number of habitats. Reshuffling mycoplasmas genetic information and evolving rapidly is a way to avoid their host’s immune system. However, currently, only a few control measures exist against some mycoplasmosis which are far from satisfaction. This review aimed to provide an updated insight into the state of mycoplasmas as pathogens by summarizing and analyzing the comprehensive progress, current challenge, and future perspectives of mycoplasmas. It covers clinical implications of mycoplasmas in humans and domestic and wild animals, virulence-related factors, the process of gene transfer and its crucial prospects, the current application and future perspectives of nanotechnology for diagnosing and curing mycoplasmosis, Mycoplasma vaccination, and protective immunity. Several questions remain unanswered and are recommended to pay close attention to. The findings would be helpful to develop new strategies for basic and applied research on mycoplasmas and facilitate the control of mycoplasmosis for humans and various species of animals.

show abstract

Corrigendum to “Development and Evaluation of an Immuno-Capture Enzyme-Linked Immunosorbent Assay to Quantify the Mycoplasma capricolum subsp. Capripneumoniae (Mccp) Protein in Contagious Caprine Pleuropneumonia (CCPP) Vaccine”

Cited by 4 publications

References 1 publication

A mini-review on diagnosis of contagious caprine pleuropneumonia

A mini-review on diagnosis of contagious caprine pleuropneumonia

Adoption of veterinary vaccines, determining factors, and barriers in Southwest Ethiopia: Implications for livestock health and disease management strategies

Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives

Contact Info

Product

Resources

About